[引用][C] Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction: Berkowitz SD, Granger CB, Lee KL, et al. Circulation …
E Sundeil - The Journal of Emergency Medicine, 1997 - Elsevier
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction
SD Berkowitz, CB Granger, KS Pieper, KL Lee… - Circulation, 1997 - Am Heart Assoc
… heparin and the streptokinase and tissue plasminogen activator plus … Coronary Arteries
(GUSTO-I) trial 7 presented an opportunity … *A complete list of GUSTO-I Investigators has been …
(GUSTO-I) trial 7 presented an opportunity … *A complete list of GUSTO-I Investigators has been …
… of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries …
MP Hudson, CB Granger, EJ Topol, KS Pieper… - Circulation, 2001 - Am Heart Assoc
… II investigators have shown that current nonsmoking was the only independent predictor
of … among 41,299 cases of suspected acute myocardial infarction. Lancet. 1992; 339: 753–770.…
of … among 41,299 cases of suspected acute myocardial infarction. Lancet. 1992; 339: 753–770.…
… infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary …
NS Kleiman, HD White, EM Ohman, AM Ross… - Circulation, 1994 - Am Heart Assoc
… Discussion Even with modern aggressive reperfusion … Hemorrhage into the myocardium
has also been reported to be more common in patients who have received thrombolytic therapy,…
has also been reported to be more common in patients who have received thrombolytic therapy,…
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial
CB Granger, J Hirsh, RM Califf, J Col, HD White… - Circulation, 1996 - Am Heart Assoc
… This is the most likely explanation for the higher incidence of bleeding … trial of streptokinase
vs tissue plasminogen activator vs … Arteries (GUSTO) IIa Investigators. Randomized trial of …
vs tissue plasminogen activator vs … Arteries (GUSTO) IIa Investigators. Randomized trial of …
… generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I trial
…, GUSTO-I Hemostasis Substudy Group - Journal of the American …, 1998 - jacc.org
… /h for ≥48 h; the investigator could delay the heparin infusion (not the … fibrinolytic state often
induced by plasminogen activators is … (TIMI) trial—Phase I: hemorrhagic manifestations and …
induced by plasminogen activators is … (TIMI) trial—Phase I: hemorrhagic manifestations and …
[引用][C] … Plasminogen Activator for Occluded Coronary Arteries (GUSTO) I Investigators. Incidence and predictors of bleeding after contemporary thrombolytic therapy …
SD Berkowitz, CB Granger, KS Pieper, KL Lee… - Circulation, 1997
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial
RM Califf, KS Pieper, KL Lee, F Van de Werf… - Circulation, 2000 - Am Heart Assoc
… ) for Occluded Coronary Arteries (GUSTO-I) trial 4 presents a … Exclusion criteria related to
the risk of bleeding or allergy and … investigators have pointed out the poor outcomes of MI …
the risk of bleeding or allergy and … investigators have pointed out the poor outcomes of MI …
Incidence and management of complications of fibrinolytic, antiplatelet, and anticoagulant therapy
AG Rebeiz, CB Granger… - Fundamental and Clinical …, 2005 - api.taylorfrancis.com
… after treatment with intravenous tissue plasminogen activator … of contemporary thrombolytic
therapy for acute myocardial … with thrombolytic therapy for acute myocardial infarction have …
therapy for acute myocardial … with thrombolytic therapy for acute myocardial infarction have …
… in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial: an …
PB Berger, DR Holmes Jr, AL Stebbins, ER Bates… - Circulation, 1997 - Am Heart Assoc
… myocardial infarction. Although the rapid administration of … Some investigators have
wondered whether unsuccessful … Contemporary reperfusion therapy for cardiogenic shock: the …
wondered whether unsuccessful … Contemporary reperfusion therapy for cardiogenic shock: the …